News for VIVXF Stock

Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA Avivagen Announces AGM Results Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2023 Avivagen Announces Foundational Scientific and Commercial Evidence of OxC-Beta™ Product Published in Peer-Reviewed Journal Avivagen Inc. Announces Securities for Service Agreements With CEO and CSO Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2022 Avivagen Announces Publication of Peer-Reviewed Article in Food and Chemical Toxicology Journal Avivagen Announces New Dairy Customer in Mexico Avivagen Announces Receipt of Repeat Order from Asian Customer Avivagen Announces Significant Order of OxC-beta™  in Brazil Avivagen Announces Sales of Companion Animal Product and Management Change Avivagen Inc. Announces Options Grant Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2022 Avivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene (OxBC) Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth Avivagen Announces Approval in China, the World’s Largest Commercial Feed Production Market Avivagen Announces AGM Results and Update to Shareholders Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2022 Avivagen to Attend CEM Sponsored Alpha North Conference Avivagen Secures New Influential Customer in Mexico Avivagen Announces Approval in Vietnam Avivagen Announces CEO Update to Shareholders Avivagen Announces Appointment of James Nickerson as President Avivagen Secures Large OxC-beta™ Livestock Order in Asia Avivagen to Hold Webcast to Discuss Landmark Deal with AB Vista AB Vista and Avivagen Strike OxC-beta™ Supply Agreement in the United States, Brazil and Thailand Avivagen Provides Further Detail on its Third Quarter Results Ending July 31, 2021 Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2021 Avivagen Announces Strategic Changes to Support Growth in Asia and South America Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants Avivagen to Present at LD Micro Conference Presentation on June 10th, at 10:30 A.M. EST Avivagen Inc. Announces Proposed Extension of Warrants and Grant of Options Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2021 Avivagen Terminates Exclusive U.S. Sales and Distribution Agreement Avivagen Announces First Purchase Order from Large Integrated Producer in Asia Avivagen Announces Largest Single Customer Purchase Order Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee Avivagen Announces Results From Its Annual General Meeting April 8, 2021 AVIVAGEN to Present at The LD 500 Virtual Conference Avivagen Inc. Announces TSX Venture Exchange Approval for Extension of Warrants Avivagen Inc. Announces Stock Option Grants Avivagen Inc. Announces Proposed Extension of Warrants Avivagen Announces Upcoming Research Publication Highlighting The Benefits Of OxC-betaTM Livestock for Broiler Poultry Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2021 Avivagen Selects Meyenberg International Group to Spearhead Expansion Efforts in Central and South America Mimi’s Rock Corp. and Avivagen Announce Launch of Dr. Tobias Beta Blend on Amazon.com Avivagen Announces Six Tonne Order of OxC-beta™ Livestock from New Customer in Mexico Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2020